Combination of tetrandrine and cisplatin synergises cytotoxicity and apoptosis in triple negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of tetrandrine and cisplatin synergises cytotoxicity and apoptosis in triple negative breast cancer

Published:2020-06 Issue: Volume:10 Page:100063
ISSN:2213-7130
Container-title:Synergy
language:en
Short-container-title:Synergy

Author:

Bhagya N.,Prabhu Ashwini,Rekha P.D.,Chandrashekar K.R.

Funder

University Grants Commission

Board of Research in Nuclear Sciences

Department of Science and technology

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cell Biology,Molecular Biology,Medicine (miscellaneous)

Reference41 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7;Yao;Int. J. Oncol.,2017

3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat. Rev. Clin. Oncol.,2016

4. Cancer drug resistance: an evolving Paradigm;Holohan;Nat. Rev. Cancer,2013

5. Analysis of anticancer drugs: a review;Nussbaumera;Talanta,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe, simple and multifunctional hydroxyapatite nanoparticles for efficient overcoming of tumor multidrug resistance;Applied Materials Today;2024-10

2. 3D sponge loaded with cisplatin–CS–calcium alginate MPs utilized as a void-filling prosthesis for the efficient postoperative prevention of tumor recurrence and metastasis;RSC Advances;2024

3. Network pharmacology based investigation on the mechanism of tetrandrine against breast cancer;Phytomedicine Plus;2023-02

4. Overcoming multidrug resistance through targeting ABC transporters: lessons for drug discovery;Expert Opinion on Drug Discovery;2022-08-22

5. Synergistic effects of natural compounds and conventional chemotherapeutic agents: recent insights for the development of cancer treatment strategies;Heliyon;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3